Is there truly a risk of lymphoma from biologic therapies?
about
Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroupsCause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR)The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials.TNF-α Polymorphisms in Juvenile Idiopathic Arthritis: Which Potential Clinical Implications?Use of biologics in a patient with rheumatoid arthritis refractory to methotrexate.Golimumab and malignancies: true or false association?Lymphomatoid papulosis in a patient treated with adalimumab for juvenile rheumatoid arthritis.Adverse effects of golimumab in the treatment of rheumatologic diseases.Spinal non-Hodgkin's lymphoma mimicking a flare of disease in a patient with ankylosing spondylitis treated with anti-TNF agents: case report and review of the literature.Side-effects of anti-inflammatory therapy in uveitis.The risk of malignancy or progression of existing malignancy in patients with psoriasis treated with biologics: case report and review of the literature.Malignant melanoma of the ileo-anal pouch anastomosis after restorative proctocolectomy for ulcerative colitis: report of a caseImmunosuppressive therapy for eye diseases: Effectiveness, safety, side effects and their prevention.Development of MGUS in psoriatic patients: a possible undiagnosed event during anti-TNF-α-treatment.Monoclonal gammopathy of undetermined significance in patients with psoriasis: is it really a side effect of biological therapy?Long-term therapy with ustekinumab for psoriasis in a patient with a history of malignant melanoma.
P2860
Q28943266-CEF9A16B-4B63-4704-9FD9-6CEF213AC9DBQ34253312-74BB97A3-7F15-4FF1-B3BE-7F2943AE5392Q34516612-B6EB5932-549C-46C8-87F3-C7F1AD918449Q34984568-22F9FD93-FF27-4650-9D02-994A9BE26BC4Q36361083-B860B701-B00E-49F8-91CC-6CE2D9A887D1Q36923376-17D768FE-0959-4775-8EC9-8C8FF1DD9DFEQ37725721-D8C9B5AB-FAE9-4D49-9C7B-F2B813D94673Q38069053-5B4897B0-E700-4EF6-B98B-B01A08102401Q38132273-D6E8EF98-2CB7-40F1-BF38-9066DC15F099Q38202031-ED3EBA0B-CE34-4C1A-B712-46E6959AEAD8Q38261127-4D8CFD99-B1BE-41E6-BB2A-88DD9EB65F5CQ38681514-942A1512-F5B1-44C0-8001-6C3C96D29370Q42029056-A858393B-5B32-4A87-B094-3E74E7E4DD3CQ42359937-05868DB5-CB86-41B4-BC96-7F1D5AAD096DQ43461744-976A11DD-FFD8-4DB5-AFE4-8D9CAAEF3A3FQ44721338-6CA64096-66F5-453F-9C6E-4E5B2FB376F6Q48089618-21F2B7EB-D873-438C-864A-DA7EAB17CC13
P2860
Is there truly a risk of lymphoma from biologic therapies?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Is there truly a risk of lymphoma from biologic therapies?
@en
Is there truly a risk of lymphoma from biologic therapies?
@nl
type
label
Is there truly a risk of lymphoma from biologic therapies?
@en
Is there truly a risk of lymphoma from biologic therapies?
@nl
prefLabel
Is there truly a risk of lymphoma from biologic therapies?
@en
Is there truly a risk of lymphoma from biologic therapies?
@nl
P2860
P1433
P1476
Is there truly a risk of lymphoma from biologic therapies?
@en
P2093
Erica Dommasch
Joel M Gelfand
P2860
P304
P356
10.1111/J.1529-8019.2009.01258.X
P577
2009-09-01T00:00:00Z